[HTML][HTML] The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications
P Economopoulou, C Perisanidis… - Annals of …, 2016 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinoma (HNSCC) carries a poor prognosis, with low
survival rates for advanced stage tumors and minimal improvement in survival trends …
survival rates for advanced stage tumors and minimal improvement in survival trends …
HPV positive head and neck cancers: molecular pathogenesis and evolving treatment strategies
R Dok, S Nuyts - Cancers, 2016 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous disease that
is the result of tobacco and/or alcohol abuse or infection with high-risk Human …
is the result of tobacco and/or alcohol abuse or infection with high-risk Human …
Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 phase III registration trial for patients with locoregionally advanced …
DI Rosenthal, PM Harari, J Giralt, D Bell… - Journal of Clinical …, 2016 - ascopubs.org
Purpose We conducted a retrospective evaluation of the IMCL-9815 study to examine the
association of human papillomavirus (HPV) and p16 protein expression status with …
association of human papillomavirus (HPV) and p16 protein expression status with …
Anti-EGFR targeted monoclonal antibody isotype influences antitumor cellular immunity in head and neck cancer patients
Purpose: EGF receptor (EGFR) is highly overexpressed on several cancers and two targeted
anti-EGFR antibodies which differ by isotype are FDA-approved for clinical use. Cetuximab …
anti-EGFR antibodies which differ by isotype are FDA-approved for clinical use. Cetuximab …
Molecular profiling of head and neck squamous cell carcinoma
R Feldman, Z Gatalica, J Knezetic, S Reddy… - Head & …, 2016 - Wiley Online Library
Background Head and neck squamous cell carcinoma (HNSCC) exhibits high rates of
recurrence, and with few approved targeted agents, novel treatments are needed. We …
recurrence, and with few approved targeted agents, novel treatments are needed. We …
[HTML][HTML] Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell …
F Braig, M Voigtlaender, A Schieferdecker, CJ Busch… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a
substantial proportion of patients with head and neck squamous cell carcinoma - PMC Back to …
substantial proportion of patients with head and neck squamous cell carcinoma - PMC Back to …
Recommendations for the prophylactic management of skin reactions induced by epidermal growth factor receptor inhibitors in patients with solid tumors
RD Hofheinz, G Deplanque, Y Komatsu… - The …, 2016 - academic.oup.com
Inhibition of the epidermal growth factor receptor (EGFR) is an established treatment that
extends patient survival across a variety of tumor types. EGFR inhibitors fall into two main …
extends patient survival across a variety of tumor types. EGFR inhibitors fall into two main …
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
AG Sacco, FP Worden - OncoTargets and therapy, 2016 - Taylor & Francis
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present
with locally advanced disease, which requires site-specific combinations of surgery …
with locally advanced disease, which requires site-specific combinations of surgery …
[HTML][HTML] Updated overview of current biomarkers in head and neck carcinoma
K Dahiya, R Dhankhar - World journal of methodology, 2016 - ncbi.nlm.nih.gov
Squamous cell cancer is the most common type of malignancy arising from the epithelial
cells of the head and neck region. Head and neck squamous cell carcinoma (HNSCC) is …
cells of the head and neck region. Head and neck squamous cell carcinoma (HNSCC) is …
Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives
S Ausoni, P Boscolo-Rizzo, B Singh… - Cancer and Metastasis …, 2016 - Springer
Despite improvements in functional outcomes attributable to advances in radiotherapy,
chemotherapy, surgical techniques, and imaging techniques, survival in head and neck …
chemotherapy, surgical techniques, and imaging techniques, survival in head and neck …